Actively Recruiting
Therapeutic Effects of Jing Si Herbal Tea for COPD
Led by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Updated on 2024-09-05
120
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung tissue damage. Jing Si herbal tea (JSHT) is known to have anti-inflammatory effects but has not been explored for treating COPD. This study investigated the potential of JSHT as an adjuvant therapy for COPD. This randomized controlled study focused on patients with COPD in the exacerbation and stable phases. The control group received the standard treatment, and the JSHT group received the standard treatment plus JSHT. Both groups underwent HRQL assessments, blood tests, and cellular studies involving five different groups to assess the effect of JSHT on damage-associated molecular patterns (DAMPs) and inflammatory markers.
CONDITIONS
Official Title
Therapeutic Effects of Jing Si Herbal Tea for COPD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- COPD patients willing to enter this study
You will not qualify if you...
- Not COPD patients
- Not willing to enter this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Taipei Tzu Chi Hospital
New Taipei City, Xindan, Taiwan, 23142
Actively Recruiting
Research Team
C
Chou-Chin Lan, MD, PHD
CONTACT
Y
Yao-Kuang Wu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here